Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Due to the pro rata system operated by BPL, even when the Northern RTC sent the same amount of plasma as the previous year, they could receive 50% less product back because other RTCs had increased their production and Northern RTC had thus supplied a smaller proportion of the total plasma that year.

  • Read more about Due to the pro rata system operated by BPL, even when the Northern RTC sent the same amount of plasma as the previous year, they could receive 50% less product back because other RTCs had increased their production and Northern RTC had thus supplied a smaller proportion of the total plasma that year.

There were periods of difficulty for the Northern RTC in terms of donor numbers as a result of shipyards and steelworks closing down in the North East and the loss of donors who had donated at workplace sessions.

  • Read more about There were periods of difficulty for the Northern RTC in terms of donor numbers as a result of shipyards and steelworks closing down in the North East and the loss of donors who had donated at workplace sessions.

The Northern RTC had no role in allocating product, they acted as an intermediary in transferring product between BPL and the end user.

  • Read more about The Northern RTC had no role in allocating product, they acted as an intermediary in transferring product between BPL and the end user.

Until Dr Huw Lloyd joined the Northern Centre, there had been only one full-time consultant at the centre.

  • Read more about Until Dr Huw Lloyd joined the Northern Centre, there had been only one full-time consultant at the centre.

Dr Huw Lloyd told the Inquiry that a third barrier to the Northern RTC meeting its targets was the RHA's approach to funding plasma collection.

  • Read more about Dr Huw Lloyd told the Inquiry that a third barrier to the Northern RTC meeting its targets was the RHA's approach to funding plasma collection.

The Northern Centre was producing the third highest amount of plasma in England and Wales, behind North London and Yorkshire.

  • Read more about The Northern Centre was producing the third highest amount of plasma in England and Wales, behind North London and Yorkshire.

Yorkshire was an early adopter of automated plasmapheresis, first opening a centre in Bradford.

  • Read more about Yorkshire was an early adopter of automated plasmapheresis, first opening a centre in Bradford.

Yorkshire RTC's 1990 target for plasma was revised down.

  • Read more about Yorkshire RTC's 1990 target for plasma was revised down.

The Yorkshire RTC failed to meet its plasma targets due to an industrial dispute, increased use of cryoprecipitate and fresh frozen plasma locally and the loss of 10,000 donations.

  • Read more about The Yorkshire RTC failed to meet its plasma targets due to an industrial dispute, increased use of cryoprecipitate and fresh frozen plasma locally and the loss of 10,000 donations.

The South West RTC increased its plasma offering to BPL by getting agreement from treating haematologists in its region to restrict the amount of cryoprecipitate (produced from locally sourced plasma) in favour of the use of Hemofil.

  • Read more about The South West RTC increased its plasma offering to BPL by getting agreement from treating haematologists in its region to restrict the amount of cryoprecipitate (produced from locally sourced plasma) in favour of the use of Hemofil.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 661
  • Page 662
  • Page 663
  • Page 664
  • Current page 665
  • Page 666
  • Page 667
  • Page 668
  • Page 669
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.